Lietuvos endokrinologų draugija - financials and debts

Company age: 34 y. 6 mo.

Update

Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue - 7,000 2,900 10,300 56,001 58,279 45,189 57,119
Profit before tax - - - - 0 0 0 0
Net profit - - - - 0 0 0 0
Equity 0 0 0 0 0 0 0 0
Liabilities 0 5,950 3,685 3,520 2,854 10,787 2,822 16,844
Non-current assets 0 0 0 0 0 0 0 0
Current assets 3,085 15,279 55,010 77,006 95,240 115,334 124,907 168,731
Total assets 3,085 15,279 55,010 77,006 95,240 115,334 124,907 168,731
Financial indicators
Revenue change y/y - - -58.6% +255.2% +443.7% +4.1% -22.5% +26.4%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. - - - - 0.0% 0.0% 0.0% 0.0%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - - - - - - - -
Profit margin Net profit margin. Shows the overall profitability of the company. - - - - 0.0% 0.0% 0.0% 0.0%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - - - - 0.0% 0.0% 0.0% 0.0%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - - - - - - -
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - - - - - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Social security debts

The company had no debts to Sodra

VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Lietuvos endokrinologu draugija (company code 190726471) is an Association operating in activities of professional membership organisations. In the latest financial year, 2025, it generated revenue of €57.1K, which was 26.4% higher than in 2024, when revenue was €45.2K. Over the two-year period from 2023 to 2025, revenue was broadly stable, declining slightly from €58.3K to €57.1K. The balance sheet strengthened over the same period: total assets increased from €115.3K in 2023 to €124.9K in 2024 and reached €168.7K in 2025. Liabilities were €10.8K in 2023, €2.8K in 2024 and €16.8K in 2025. In 2025, total assets were fully composed of short-term assets, indicating a liquid asset base. The latest asset turnover ratio was 0.34x, reflecting moderate use of assets to generate revenue in 2025.